Four drugs approved by the FDA since Oct. 3:
Pharmacy
The California State Board of Pharmacy invalidated 1,400 pharmacists' state exam scores after it discovered around 100 exam questions were leaked online, according to the Los Angeles Times.
Two congressional committees approved House Speaker Nancy Pelosi's drug pricing bill Oct. 17, leaving just two more committees to vote on it before it goes to the full House floor, according to CNBC.
Three Vermont lawmakers sent a letter to the FDA Oct. 18 accusing the agency of failing to be transparent about Takeda Pharmaceutical's recall of the lifesaving drug Natpara. The lawmakers also called on the agency to quickly resolve the shortage…
Johnson & Johnson will lay off 297 employees at its facility in Wayne, Pa., according to The Philadelphia Inquirer.
Columbus, Ohio-based Mount Carmel West Hospital and three of its pharmacists have been cited by the Ohio Board of Pharmacy for approving or failing to prevent fatal doses of pain medications from being administered to 28 near-death patients, according to…
Citing a need to shift resources to different research and development projects, Merck said it will eliminate 500 U.S. jobs by Jan. 3, according to EndPoints News.
Johnson & Johnson and its subsidiary Ethicon will pay nearly $117 million to settle claims that they misrepresented the risks of transvaginal surgical mesh devices, according to The Wall Street Journal.
A majority of Americans want Congress to pass legislation to lower drug costs, but don't know what measures should be taken to achieve that goal, a poll by the Kaiser Family Foundation found.
MinuteClinic, CVS Health's retail medical clinic, launched telehealth programs in two more states.